OTC glucosomine supplements threatened

Article Abstract:

The United States Food and Drug Administration's Center for Veterinary Medicine has released an "informal opinion" regarding animal dietary supplements and pet foods that claim to treat or cure joint problems with glucosamine or chondroitin. The office stated that it cannot classify the two supplements "generally regarded as safe" (GRAS) for use in the over-the-counter supplements and pet foods. These two supplements are considered GRAS for humans.

Grain Mill Products, Pet Food, Animal Food Manufacturing, Standards, Chondroitin, Glucosamine, Animal health

---

BIV inhaler for equine "asthma."(Boehringer Ingelheim Vetmedica receives FDA approval for Torpex, equine-specific inhaler)

Article Abstract:

Boehringer Ingelheim Vetmedica has received approval from the Food and Drug Administration for its equine inhaler, Torpex, which is combined albuterol sulfate. Torpex is for horses with recurrent airway obstruction.

Germany, Surgical Appliance and Supplies Manufacturing, Surgical and medical instruments, Inhalators, Health aspects, Product introduction, Horses, United States. Food and Drug Administration, Inhalers, Boehringer Ingelheim Vetmedica Inc., Torpex (Medication)

---

US drug approvals for 2001

Article Abstract:

The article lists the approval by the Food and Drug Administration's Center for Veterinary Medicine for new animal drugs for 2001. Companies, products and indication information are given.

Europe

Similar abstracts:

• Abstracts: SME raises profit. Kablo Kladno strengthened its proceeds in 2000. Severomoravska Energetika reports a profit
• Abstracts: A matter of interpretation. US dangles listing carrot. Blueprint for the future
• Abstracts: Charging clients: find the best method to suit your needs. Planning to prosper in '06. Be selective in choosing whether to pursue an RFP
• Abstracts: Ceva's two-step Flexivet in UK. New cattle feed additives from Sano. VivoBay for horses & dogs
• Abstracts: French AH sales up 4% by Sept. Aust market thriving, NZ shaky. Novartis AH's 9-month fall

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.